AGER and atrial fibrillation: DAPA significantly suppressed the expression of HMGB1, RAGE, IL-1β, and IL-6, which suggests that DAPA inhibits the HMGB1/RAGE pathway and mitigates the inflammatory response induced by AF (Figure 7b, p < 0.05).